Efficacy and Safety of Onabotulinum Toxin A (Botox) Injections in the Upper Esophageal Sphincter for the Treatment of Pharyngo-esophageal Dysphagia Due to Cricopharyngeal Dysfunction- A Randomized Double Blinded Placebo Controlled Trial
Latest Information Update: 18 Sep 2023
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Deglutition disorders; Muscle spasticity; Oesophageal disorders
- Focus Therapeutic Use
- 11 Sep 2023 Status changed from not yet recruiting to recruiting.
- 07 Jan 2021 New trial record